Search research articles
Contact Us
Filters
Showing results (131-140 of 301) with videos related to
Page
of 31
Sort By:
Journal of Internal Medicine
|
October 1, 2008
C-reactive protein and coronary heart disease: a critical review
J P Casas, T Shah, A D Hingorani, et al.
Gut
|
October 1, 1975
Proceedings: Complement dependence of IgA antibody production
M B Pepys, M H Wansbrough-Jones, A C Dash, et al.
FEBS Letters
|
May 17, 2000
Molecular chaperone properties of serum amyloid P component
A R Coker, A Purvis, D Baker, et al.
Immunology
|
October 1, 1986
Isolation and characterization of guinea-pig serum amyloid P component
S Maudsley, C R Hind, E A Munn, et al.
Clinical and Experimental Immunology
|
September 1, 1984
'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils
D Caspi, M L Baltz, A Feinstein, et al.
Clinical and Experimental Immunology
|
September 1, 1984
The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis
M L Baltz, D Caspi, B E Glatthaar, et al.
Clinical and Experimental Immunology
|
June 1, 1984
C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy
M J Ridley, D S Ridley, F C De Beer, et al.
Lancet (London, England)
|
March 20, 2001
Effect of alcohol consumption on systemic markers of inflammation
A Imhof, M Froehlich, H Brenner, et al.
Nature Medicine
|
April 3, 2001
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie
N A Mabbott, M E Bruce, M Botto, et al.
Lancet (London, England)
|
February 15, 1997
Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
F Haverkate, S G Thompson, S D Pyke, et al.
Page
of 31
Search research articles
Search
Showing results (131-140 of 301) with videos related to
Sort By:
Page
of 31
Journal of Internal Medicine
|
October 1, 2008
C-reactive protein and coronary heart disease: a critical review
J P Casas, T Shah, A D Hingorani, et al.
Gut
|
October 1, 1975
Proceedings: Complement dependence of IgA antibody production
M B Pepys, M H Wansbrough-Jones, A C Dash, et al.
FEBS Letters
|
May 17, 2000
Molecular chaperone properties of serum amyloid P component
A R Coker, A Purvis, D Baker, et al.
Immunology
|
October 1, 1986
Isolation and characterization of guinea-pig serum amyloid P component
S Maudsley, C R Hind, E A Munn, et al.
Clinical and Experimental Immunology
|
September 1, 1984
'Amyloid degrading activity' of human serum, an in vitro clearing effect which does not involve degradation of amyloid fibrils
D Caspi, M L Baltz, A Feinstein, et al.
Clinical and Experimental Immunology
|
September 1, 1984
The failure of ascorbic acid therapy to alter the induction or remission of murine amyloidosis
M L Baltz, D Caspi, B E Glatthaar, et al.
Clinical and Experimental Immunology
|
June 1, 1984
C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy
M J Ridley, D S Ridley, F C De Beer, et al.
Lancet (London, England)
|
March 20, 2001
Effect of alcohol consumption on systemic markers of inflammation
A Imhof, M Froehlich, H Brenner, et al.
Nature Medicine
|
April 3, 2001
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie
N A Mabbott, M E Bruce, M Botto, et al.
Lancet (London, England)
|
February 15, 1997
Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
F Haverkate, S G Thompson, S D Pyke, et al.
Page
of 31